Despite the distinct mechanisms and working models, these two studies have uncovered the cholesterol metabolic program in driving tumor-infiltrating T cells in the TME, and they also have drawn the same conclusion that the cholesterol uptake-associated protein PCSK9 serves as an auspicious therapeutic target. Here, PCSK9 is linked to neoplasm.